The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Citidaron 1.5 mg tablets

Aflofarm Farmacja Polska Sp. z o.o.PA22714/001/001

Main Information

Trade NameCitidaron 1.5 mg tablets
Active SubstancesCytisine
Dosage FormTablet
Licence HolderAflofarm Farmacja Polska Sp. z o.o.
Licence NumberPA22714/001/001

Group Information

ATC CodeN07BA Drugs used in nicotine dependence


License statusAuthorised
Licence Issued05/03/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back